GUIDUCCI, SERENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.666
EU - Europa 7.128
AS - Asia 1.374
AF - Africa 15
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 7
Totale 21.215
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.632
PL - Polonia 2.682
IT - Italia 1.456
IE - Irlanda 1.185
SE - Svezia 881
HK - Hong Kong 635
CN - Cina 289
FI - Finlandia 249
DE - Germania 164
JO - Giordania 139
GB - Regno Unito 136
UA - Ucraina 133
TR - Turchia 89
IN - India 75
RU - Federazione Russa 69
VN - Vietnam 68
CH - Svizzera 58
SG - Singapore 49
ES - Italia 46
CA - Canada 33
FR - Francia 18
EU - Europa 12
NL - Olanda 12
KR - Corea 10
BE - Belgio 8
JP - Giappone 8
SC - Seychelles 8
BR - Brasile 6
AT - Austria 5
AU - Australia 5
CM - Camerun 5
LV - Lettonia 4
PT - Portogallo 4
RO - Romania 4
HU - Ungheria 3
IR - Iran 3
NO - Norvegia 3
VE - Venezuela 3
AR - Argentina 2
BA - Bosnia-Erzegovina 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TW - Taiwan 2
BO - Bolivia 1
CL - Cile 1
GE - Georgia 1
ID - Indonesia 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 21.215
Salva come PNG Salva come JPEG
Città #
Warsaw 2.680
Fairfield 2.212
Chandler 1.186
Dublin 1.177
Ashburn 1.056
Woodbridge 1.025
Seattle 899
Cambridge 869
Houston 778
Wilmington 686
Princeton 349
Lawrence 347
Hong Kong 340
Altamura 338
Ann Arbor 296
Florence 287
Jacksonville 262
Boston 199
Beijing 185
Boardman 163
Medford 154
San Diego 126
Buffalo 109
Rome 79
Izmir 78
Falls Church 75
Milan 75
Norwalk 65
Moscow 63
Pune 61
Dong Ket 54
New York 54
Shanghai 53
Singapore 46
Bern 44
Hillsboro 44
West Jordan 38
Andover 30
Barcelona 30
London 24
Redwood City 20
Toronto 20
Naples 17
Los Angeles 16
Phoenix 16
Washington 14
Redmond 12
Turin 12
Cagliari 11
Dearborn 11
Castelliri 10
Düsseldorf 10
Salerno 9
Chicago 8
Auburn Hills 7
Bari 7
Brussels 7
Laurel 7
Moie 7
Scandicci 7
Bologna 6
Bremen 6
Hefei 6
Lucca 6
Reggio Emilia 6
Sesto Fiorentino 6
Tappahannock 6
Verona 6
Città della Pieve 5
Genoa 5
Messina 5
Napoli 5
Nardò 5
Pisa 5
Santa Cruz de Tenerife 5
Vienna 5
Arosio 4
Basel 4
Bergamo 4
Caserta 4
Catania 4
Chapel Hill 4
Chiswick 4
Chiusi 4
Dawson Creek 4
Erzurum 4
Ferrara 4
Kilburn 4
Mariano Comense 4
Montevarchi 4
Padova 4
San Mateo 4
Sassari 4
Tempio Pausania 4
Arnsberg 3
Atlanta 3
Barquisimeto 3
Bayburt 3
Bom Jardim 3
Brescia 3
Totale 17.042
Salva come PNG Salva come JPEG
Nome #
ENDOMETRIOSI E MALATTIE REUMATICHE: LA PUNTA DELL’ICEBERG DEI NUMEROSI DISTURBI MESTRUALI IN CORSO DI MALATTIA REUMATICA 340
Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide 237
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient. 229
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 220
Interstitial lung disease in systemic sclerosis: Where do we stand? 217
[The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases]. 209
The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem? 209
[Peripheral nervous system in limited systemic sclerosis]. 208
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 206
[Vasculogenesis and angiogenesis: vascular damage in systemic sclerosis]. 196
High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis. 195
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 193
Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide 193
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 190
Anti-Fas IgM monoclonal antibody (anti-Fas mAb) effect on haemophilic arthropathy (HA) synoviocytes 189
A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. 185
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis. 182
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population 179
Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. 173
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis 167
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 160
Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: A challenge for the rheumatologist 122
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 119
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis 118
Systemic sclerosis-like histopathological features in the myocardium of uPAR-deficient mice 118
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 117
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 114
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 113
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 108
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 106
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 105
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction 104
Differential expression of junctional adhesion molecules in different stages of systemic sclerosis 103
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 103
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 102
Digital ulcers predict a worse disease course in patients with systemic sclerosis 102
Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis 101
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 100
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 99
Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis 98
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 96
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 96
Activin, a grape seed derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. 95
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications 95
The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis. 95
Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: placental findings. 95
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 95
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 92
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium 92
Calcinosis in systemic sclerosis: subsets, distribution and complications 91
Treatment options in systemic sclerosis 90
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 89
Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An Overview 89
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes. 88
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases 88
The safety of iloprost in systemic sclerosis in a real-life experience 88
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 87
Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production. 87
Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage 86
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. 86
Systemic sclerosis and infections. 85
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. 84
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. 84
Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis 83
Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma? 82
Etrurians vs Greeks: May ACE I/D polymorphism still be considered as a marker of susceptibility to SSc? 82
2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative 82
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 82
Stiff skin syndrome: evidence for an inflammation-independent fibrosis? 81
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. 81
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 81
Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis. 80
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. 80
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 80
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 79
Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis 79
Angiotensin-converting enzyme in systemic sclerosis: from endothelial injury to a genetic polymorphism. 79
Increased circulating levels of interleukin-33 in systemic sclerosis correlate with early disease stage and microvascular involvement 79
Functional disability and its predictors in systemic sclerosis: A study from the DeSScipher project within the EUSTAR group 79
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: A EUSTAR analysis 79
Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. 78
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. 77
Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels. 77
Circulating leptin levels in juvenile idiopathic arthritis: a marker of nutritional status? 77
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement 77
Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR). 77
Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis. 77
Induced sputum in systemic sclerosis interstitial lung disease: Comparison to healthy controls and bronchoalveolar lavage 77
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis. 76
The origin of the myofibroblast in fibroproliferative vasculopathy: does the endothelial cell steer the pathophysiology of systemic sclerosis? 76
Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis. 76
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study 75
Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. 75
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 75
Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis. 74
Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF165b splice variant 73
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 73
Immunosuppression for interstitial lung disease in systemic sclerosis. 73
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. 73
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 73
Totale 11.279
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.714
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.859 0 0 0 0 0 0 0 0 0 369 814 676
2019/20204.579 346 311 138 359 513 547 528 573 500 318 361 85
2020/20213.089 268 213 187 504 134 269 168 214 314 438 207 173
2021/20222.034 48 182 164 86 92 128 61 155 139 74 269 636
2022/20235.199 558 982 177 373 389 920 672 253 511 97 175 92
2023/20242.543 85 273 447 158 200 383 150 513 88 246 0 0
Totale 21.626